SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019705
Filing Date
2021-08-13
Accepted
2021-08-13 16:06:10
Documents
38
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 480668
2 ex31-1.htm EX-31.1 11231
3 ex31-2.htm EX-31.2 11235
4 ex32-1.htm EX-32.1 4673
5 ex32-2.htm EX-32.2 4670
  Complete submission text file 0001493152-21-019705.txt   2274936

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vbio-20210630.xsd EX-101.SCH 17218
7 XBRL CALCULATION FILE vbio-20210630_cal.xml EX-101.CAL 22259
8 XBRL DEFINITION FILE vbio-20210630_def.xml EX-101.DEF 45010
9 XBRL LABEL FILE vbio-20210630_lab.xml EX-101.LAB 164286
10 XBRL PRESENTATION FILE vbio-20210630_pre.xml EX-101.PRE 119959
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 311315
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 211172091
SIC: 8731 Services-Commercial Physical & Biological Research